Home > Drug Search >
  • company_query: Amilar
  •   > 
Drug Filter
Category:
chemistry (11) biology (26)
Status:
Approved (7) NDA Filing (1) BLA Filing (1) Phase Ⅲ (2) Phase Ⅱ (17) Phase Ⅰ (9)
Clinical Stage:
Pending (7) Active (16) Discontinued (7)
Bio-Type:
Vaccine (13) Blood extraction (1) Recombinant enzyme (1) Recombinant cytokines (6) Whole antibody (2)
Indication:
Acute coronary syndrome (ACS) (1) Anemia (1) Breast cancer (1) Cutaneous T cell lymphoma (CTCL) (1) Cystic fibrosis (CF) (1) Rheumatic disorders (1) Erectile dysfunction (ED) (3) HBV infection (3) HCV infection (2) Heart failure (1) Hypertension (1) Hyperuricemia (1) Rabies (2) Major depressive disorder (MDD) (1) Melanoma (1) Myelodysplastic syndrome (MDS) (1) Non small cell lung cancer (NSCLC) (1) Obesity (1) Osteoarthritis (OA) (1) Ovarian cancer (2) Pancreatic cancer (1) Postoperative nausea and vomiting (1) Prostate cancer (3) Botulism (1) Rheumatoid arthritis (RA) (1) Solid tumours (2) Ulcerative colitis (1) Head and neck cancer (1) Yersinia pestis infection (1) Campylobacter infections (1) Venezuelan equine encephalitis virus infection (1) Diabetic foot ulcers (1) Anthrax (1) Neutropenia (2) Septic shock (1) Smallpox infection (1) Merkel cell carcinoma (1) Plaque psoriasis (1) Ebola virus disease (EVD) (1) Chronic fatigue syndrome (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top